ロード中...
Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR‐9 pathway
Bone marrow‐derived mesenchymal stem cells (BMSCs) have great therapeutic potential for many diseases. However, the homing of BMSCs to injury sites remains a difficult problem. Recent evidence indicates that simvastatin stimulates AKT phosphorylation, and p‐AKT affects the expression of chemokine (C...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831354/ https://ncbi.nlm.nih.gov/pubmed/26871266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12795 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|